National academy of clinical biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases

Clinical Chemistry

Volumn 45, Issue 7, 1999, Pages 1104-1121

  Wu, Alan H B ^a   Apple, Fred S ^b   Gibler, W Brian ^c   Jesse, Robert L ^d   Warshaw, Myron M ^e   Valdes Jr , Roland ^f  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e NORTHWEST COMMUNITY HOSPITAL   (United States)

^f University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ACUTE HEART INFARCTION; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL LABORATORY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; HOSPITAL MANAGEMENT; PRACTICE GUIDELINE; REVIEW; THORAX PAIN;

EID: 0032808596     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.7.1104     Document Type: Review

References (119)

1. Tierney WM, Fitzgerald J, McHenry R, Roth BJ, Psaty B, Stump DL, Anderson FK. Physicians' estimates of the probability of myocardial infarction in emergency room patients with chest pain. Med Decis Making 1986;6:12-7.
2. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-428.
3. The Cardiology Roundtable. Perfecting MI ruleout. Best practices for emergency evaluation of chest pain. Washington, DC: The Advisory Board Co., 1994:15 pp.
4. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987;60:219-24.
5. Lewas S. Paradox, process and perception: the role of organizations in clinical practice guidelines development. Can Med Assoc J 1995;153:1073-7.
6. Cohn PF. Silent myocardial ischemia and infarction, 2nd ed. New York: Marcel Dekker, 1989:1-3.
7. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993;88:750-63.
8. Apple FS, Preese LM, Panteghini M, Vaidya HC, Bodor GS, Wu AHB. Markers for myocardial injury. J Clin Immunoassay 1994;17:6-48.
9. Ohman EM, Casey C, Bengston JR, Pryor D, Tormey W, Horgan JH. Early detection of acute myocardial infarction: additional information from serum concentration of myoglobin in patients without ST elevation. Br Heart J 1990;63:335-8.
10. Hamilton RW, Hopkins MB, Shihabi ZK. Myoglobinuria, hemoglobinuria, and acute renal failure [Clinical Conference]. Clin Chem 1989;35:1713-20.
11. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
12. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953-8.
13. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
14. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CCC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-7.
15. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991;83:902-12.
16. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosis of acute myocardial infarction. Clin Chem 1996;42:1770-6.
17. Hafner G, Thome-Kromer B, Schaube J, Kupferwasser I, Ehrenthal W, Cummins P, et al. Cardiac troponins in serum in chronic renal failure [Letter]. Clin Chem 1994;40:1790-1.
18. Li D, Jialal I, Keffer J. Greater frequency of increased cardiac troponin T than increased cardiac troponin T in patients with chronic renal failure [Letter]. Clin Chem 1996;42:114-5.
19. Wu AHB, Feng YJ, Roper E, Herbert C, Schweizer R. Cardiac troponins T and I before and after renal transplantation [Letter]. Clin Chem 1997;43:411-2.
20. Apple FS, Sharkey SW, Hoeft P, Skeate R, Boss E, Dahlmeier BA, Preese LM. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 1997;29:399-403.
21. Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997;43:476-84.
22. Haller C, Zehelein J, Remppis A, Muller-Bardorff M, Katus HA. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem 1998;44:930-8.
23. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998;44:1919-24.
24. Porter GA, Norton TL, Bennett WM. Troponin T (TnT), a predictor of death in chronic hemodialysis patients (CHDP) [Abstract]. Am J Kidney Dis 1998;31:A27.
25. Van Lente F, McErlean ES, DeLuca SA, Peacock F, Rao JS, Nissen SE. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 1999;33:471-8.
26. Chapelle JP, Albert A, Smeets JP, Boland J, Heusghem C, Kulbertus HE. Serum myoglobin determinations in the assessment of acute myocardial infarction. Eur Heart J 1982;3:122-9.
27. Pervaiz S, Anderson FP, Lohman TP, Lawson CJ, Feng YJ, Waskiewicz D, et al. Comparative analysis of cardiac troponin I and CK-MB as markers of acute myocardial infarction. Clin Cardiol 1997;20:269-71.
28. Maddison A, Craig A, Yusuf S, Lopez R, Sleight P. The role of serum myoglobin in the detection and measurement of myocardial infarction. Clin Chim Acta 1980;106:17-28.
29. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995;41:1266-72.
30. Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, Perryman MB. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990;82:759-64.
31. Puleo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin Chem 1989;35:1452-5.
32. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573-8.
33. The Thrombolysis in Myocardial Infarction (TIMI) Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial Phase I findings. N Engl J Med 1985;312:932-6.
34. The GISSI Study Group. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
35. Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980;26:1241-50.
36. World Health Organization. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607-9.
37. Marmor A, Sobel BE, Robert R. Factors presaging early recurrent myocardial infarction ("extension"). Am J Cardiol 1981;48:603-10.
38. Wu AHB, Laios I, Green S, Gornet TG, Wong SS, Parmley L, et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994;40:796-802.
39. Chapelle JP, Bertrand A, Heughem C. The protection of creatine kinase MM sub-forms by EDTA during storage. Clin Chim Acta 1981;115:255-62.
40. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986;105:221-33.
41. Gibler WB, Lewis LM, Erb RE, Makens PK, Kaplan BC, Vaughn RH, et al. Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med 1990;19:1359-66.
42. Gibler WB, Gibler CD, Weinshenker E, Abbottsmith C, Hedges JR, Barsan WG, et al. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med 1987;16:851-6.
43. Panteghini M, Pagani F. Diagnostic value of a single measurement of troponin T in serum for suspected acute myocardial infarction [Letter]. Clin Chem 1994;40:673-4.
44. Sabar R, Gul K, Deedwania PC. Troponin-I alone is adequate for the diagnosis of acute myocardial infarction; is it necessary to do multiple enzymatic assays? [Abstract]. J Am Coll Cardiol 1999;33(Suppl A):345A.
45. Muller-Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical evaluation. Clin Chem 1997;43:458-66.
46. Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson HJ, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
47. Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO IIa Investigators. Circulation 1998;98:1853-9.
48. Fuster V, Badimon L, Badimon JJ, Cheseboro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part 1. N Engl J Med 1992;326:242-50.
49. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
50. Wu AHB, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem 1994;40:900-7.
51. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
52. Ravkilde J, Horder M, Gerhardt W, Ljungdahl L, Pettersson T, Tryding N, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scan J Clin Lab Investig 1993;53:677-85.
53. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification with admission cardiac troponin T levels in acute myocardial ischemia. The GUSTO IIa Investigators. N Engl J Med 1996;335:1333-41.
54. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
55. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;43:2053-9.
56. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. The Thrombin Inhibition in Myocardial Ischemia Study Group. Circulation 1997;96:2578-85.
57. Olatidoye AG, Wu AHB, Feng YJ, Waters D. Prognostic role of troponin T versus I in unstable angina for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998;81:1405-10.
58. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The Fragmin during Instability in Coronary Artery Disease Study Group. Circulation 1996;93:1651-7.
59. Jesse RL. Myocardial necrosis in "pure unstable angina": identification of high-risk subgroups or a contradiction in terms? Am Heart J 1999;137:190-2.
60. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997;29:43-8.
61. Hamm CW, Heeschen C, Goldmann BU, Barnathan E, Simoons ML. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina [Abstract]. J Am Coll Cardiol 1998;31(Suppl A):185A.
62. Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991;37:1405-11.
63. Keffer JH. Why cardiospecificity is preeminent in myocardial markers of injury. Clin Lab Med 1997;14:727-35.
64. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel II). JAMA 1993;269:3015-23.
65. Thayapran N, Prigent F, Steingart R, Feng YJ, Lowenkron D, Wu A. Is there a release of cardiac troponin during exercise testing? [Abstract]. Circulation 1997;96(Suppl):I-461.
66. Kwong TC, Fitzpatrick PG, Rothbard RL. Activities of some enzymes in serum after therapy with intracoronary streptokinase in acute myocardial infarction. Clin Chem 1984;30:731-4.
67. Califf RM, O'Neil W, Stack RS, Aronson L, Mark DB, Mantell S, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988;108:658-62.
68. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542-50.
69. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996;105:6-10.
70. Christenson RH, Ohman EM, Topol EJ, Peck S, Newby LK, Duh SH, et al. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group Thrombolysis and Angioplasty in Myocardial Infarction-7. Circulation 1997;96:1776-82.
71. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44-9.
72. Balderman SC, Bhayana JN, Steinbach JJ, Masud AR, Michalek S. Perioperative myocardial infarction: a diagnostic dilemma. Ann Thorac Surg 1980;30:370-7.
73. Strom S, Bendz R, Olin C, Lundberg S. Serum enzymes with special reference to CK-MB following coronary bypass surgery. Scand J Thorac Cardiovasc Surg 1979;13:53-9.
74. Katus HA, Schoeppenthau M, Tanzeem A, Bauer HG, Saggau W, Diederich KW, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J 1991;65:259-64.
75. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995;59:1192-4.
76. Metzler H, Gries M, Rehak P, Lang TH, Fruthwald S, Toller W. Perioperative myocardial cell injury: the role of troponins. Br J Anaesth 1997;78:386-90.
77. Grande P, Christiansen C, Alstrup K. Comparison of ASAT, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in man. Clin Chim Acta 1983;128:329-35.
78. Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Investig 1977;61:1048-56.
79. Nagai R, Chiu CC, Yamaoki K, Ohuchi Y, Ueda S, Imataka K, Yazaki Y. Evaluation of methods for estimating infarct size by myosin LC2: comparison with cardiac enzymes. Am J Physiol 1983;245:H413-9.
80. Maxwell SR, Lip GY. Raperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1998;58:95-117.
81. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. Document C28-A. Villanova, PA: NCCLS, 1995.
82. Sasse EA. Reference intervals and clinical decision limits. In: Kaplan LA, Pesce AJ, eds. Clinical chemistry theory, analysis, and correlation, 3rd ed. St. Louis: Mosby, 1996:370-1.
83. Henderson AR, Bhayana W. A modest proposal for the consistent presentation of ROC plots in Clinical Chemistry [Abstract]. Clin Chem 1995;41:1205-6.
84. Missov ED, DeMarco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta 1999;in press.
85. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
86. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
87. Carville DGM, Dimitrijevic N, Walsh M, Digirolamo T, Brill EM, Drew N, Gargan PE. Thrombus precursor protein (TpP): marker of thrombosis early in the pathogenesis of myocardial infarction. Clin Chem 1996;42:1537-41.
88. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, et al. Increased soluble form of p-selectin in patients with unstable angina. Circulation 1995;92:1693-6.
89. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995;41:966-78.
90. van Nieuwenhoven FA, Kleine AH, Wodzig KWH, Hermens WT, Kragten HA, Maessen JG, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-54.
91. Vuori J, Syrjala H, Vaananen HK. Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. Clin Chem 1996;42:107-9.
92. Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci 1997;34:1-66.
93. Apple FS. Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s. Am J Clin Pathol 1992;97:217-26.
94. Apple FS, Sharkey S, Falahati A, Christensen D, Miller E, McCoy M, Murakami MA. A prospective study of implementing cardiac troponin I testing for detection of myocardial infarction [Abstract]. Clin Chem 1996;42:S97.
95. Martins JT, Li DJ, Baskin LB, Jialal I, Keffer JH. Comparison of cardiac troponin I and lactate dehydrogenase isoenzymes for the late diagnosis of myocardial injury. Am J Clin Pathol 1996;106:705-8.
96. Wu AHB, Perryman MB. Clinical applications of muscle enzymes and proteins. Curr Opin Rheumatol 1992;4:815-20.
97. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum following acute myocardial infarction, and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 1998;44:1198-208.
98. Wu AHB. Laboratory and near patient testing for cardiac markers. J Clin Ligand Assay 1999;22:32-7.
99. Fitzmaurice TF, Brown C, Rifai N, Wu AH, Yeo KT. False increase of cardiac troponin I with heterophile antibodies. Clin Chem 1998;44:2212-4.
100. Revision of troponin policy. Medicare Part A. Newsletter 004-98. Dallas, TX: Health Care Financing Administration, August 1998:6-7.
101. mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-7.
102. Wu AHB, Wang X-M, Gornet TG, Ordonez-Llanos J. Creatine kinase MB isoforms in patients with myocardial infarction and skeletal muscle injury. Ramifications for early detection of acute myocardial infarction. Clin Chem 1992;38:2396-400.
103. el Allaf M, Chapelle JP, el Allaf D, Adam A, Faymonville ME, Laurent P, Heusghem C. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clin Chem 1986;32:291-5.
104. Koch TR, Mehta UJ, Nipper HC. Clinical and analytical evaluation of kits for measurement of creatine kinase isoenzyme MB. Clin Chem 1986;32:186-91.
105. Lott JA, Heinz JW, Reger KA. Time changes of creatine kinase and creatine kinase-MB isoenzyme versus discrimination values in the diagnosis of acute myocardial infarction: what is the optimal method for displaying the data? Eur J Clin Chem Clin Biochem 1995;33:491-6.
106. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from the National Heart Attack Alert Program Working Group. Ann Emerg Med 1997;29:13-87.
107. Wu AHB, Clive J. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem 1997;43:326-32.
108. Anderson FP, Jesse RL, Nicholson CS, Miller WG. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction. In: Bowie LJ, ed. Assessing clinical outcomes. Utilizing appropriate laboratory testing to decrease healthcare costs and improve patient outcomes. Washington, DC: AACC Leadership Series, 1996:20-4.
109. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for the detection of serum cardiac troponin T. JAMA 1995;273:1279-82.
110. Brogan GX, Bock JL, McCuskey CF, Hollander JE, Thode H Jr, Gawad Y, Jackowski G. Evaluation of Cardiac STATus CK-MB/Myoglobin device for rapidly ruling out myocardial infarction. Clin Lab Med 1997;17:655-8.
111. Collinson PO, Gerhardt W, Katus HA, Muller-Bardorff M, Braun S, Schricke U, et al. Multicenter evaluation of an immunological rapid test for the detection of troponin T in whole blood samples. Eur J Clin Chem Clin Biochem 1996;34:591-8.
112. Apple FS, Christenson RH, Valdes R Jr, Wu AHB, Andriak AJ, Duh SH, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB and cardiac troponin I by the Triage Cardiac Panel for detection of myocardial infarction. Clin Chem 1999;45:199-205.
113. Collinson PO, John C, Cramp DRG, Canepa-Anson R. Prospective randomised controlled trial of point of care testing with central laboratory testing for cardiac enzyme measurement [Abstract]. Clin Chem 1998;44:A69.
114. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DBP, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 1990;36:892-4.
115. Fitzmaurice TF, Brown C, Rifai N, Wu AHB, Yeo KTJ. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:2212-4.
116. Panteghini M, Pagani F. Biological variation of myoglobin in serum [Letter]. Clin Chem 1997;42:2435.
117. Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998;35:80-4.
118. Liao R, Wang CK, Cheung HC. Coupling of calcium to the interaction of troponin I with troponin C from cardiac muscle. Biochemistry 1994;33:12729-34.
119. Hyams AL, Brandenburg JA, Lipsitz SR, Shapiro DW, Brennan TA. Practice guidelines and malpractice litigations: a two-way street. Ann Intern Med 1995;122:450-5.